NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Amyloid beta (Aβ)-induced abnormal neuroinflammation is recognized as a major pathological feature of Alzheimer’s disease (AD), which results in memory impairment. Research exploring low-grade systemic inflammation and its impact on the development and progression of neurodegenerative disease has in...
Main Authors: | Giulia Sita, Agnese Graziosi, Patrizia Hrelia, Fabiana Morroni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/6984 |
Similar Items
-
The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease
by: Kendra L. Hanslik, et al.
Published: (2020-09-01) -
Editorial: The NLRP3 inflammasome-mediated neuroinflammation and its related mitochondrial impairment in neurodegeneration
by: Chao Deng, et al.
Published: (2023-01-01) -
Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
by: Ullah A, et al.
Published: (2022-07-01) -
α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes
by: Taraneh Ebrahimi, et al.
Published: (2018-09-01) -
Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment [Retraction]
by: Ullah A, et al.
Published: (2022-11-01)